Skip to content

Behavioral Memory Modulation in Nicotine Addiction

Targeting Foundational Memory Processes in Nicotine Addiction: A Translational Clinical Neuroscience Study of a Retrieval-Extinction Intervention to Reduce Craving and Smoking Behavior

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03744559
Enrollment
191
Registered
2018-11-16
Start date
2019-02-04
Completion date
2023-11-01
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Use Disorder

Brief summary

The purpose of the study is to see if a behavioral intervention known as retrieval-extinction training (RET) might affect craving in response to nicotine cues (e.g., pictures, videos and objects) and smoking behavior in men and women who smoke cigarettes.

Detailed description

In a recently published NIDA-funded study, the investigators found that lasting reductions in craving and smoking could be achieved with a brief behavioral intervention designed to alter memory processes underlying smoking-related nicotine addiction. The proposed project will replicate and extend these findings by 1) increasing the dose of intervention so as to bolster the observed treatment effects, 2) employing brain imaging methods to identify patterns of brain activity uniquely associated with the intervention and potentially predictive of treatment outcome, 3) extending follow-up period to more completely document the long-term effects of the intervention. Positive findings from this study could lead to the development of brief therapy that will not only improve treatment outcomes for smokers, but also be used in the treatment other substance use disorders and frequently co-occurring comorbidities such as PTSD.

Interventions

BEHAVIORALRetrieval Extinction Training (RET)

Retrieval extinction training (RET) is a behavioral intervention that involves cue-elicited retrieval followed by extinction training (i.e., massed unreinforced exposure to drug-associated cues). The first element of RET involves briefly presenting drug-associated cues to retrieve drug use memories. The second element, occurring after a brief interval, involves extinction training. It is argued that the initial retrieval of the memories prior to extinction training initiates a period of instability, which is followed by reconsolidation of the memories back into long-term storage. Extinction training during the period of instability is presumed to overwrite the original drug-associated cue with a non-drug-associated cue, to attenuate expression of drug-seeking behavior.

BEHAVIORALControl Retrieval Extinction Training (RET)

The control retrieval extinction training (RET) for the NR-E arms serves as the control intervention to the RET behavioral intervention. The first element of the control RET involves briefly presenting retrieval cues that contain neutral, non-smoking content. The second element, occurring after a brief interval, involves extinction training. Based on findings from the previous NIDA-funded R21, the R-E arm reported a significant 25 percent reduction in cigarettes smoked per day during the follow-up period versus the control NR-E arm.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy men and women, ages 25 to 65, who have smoked at least 10 cigarettes per day for at least 3 years. 2. Participants must live within a 50-mile radius of the research facility and have reliable transportation. 3. Participants must be willing to abstain from smoking starting the night before the baseline visit, and starting the night before visit 1 and remain abstinent for four consecutive days. 4. Participants must agree to forego any other medication or behavioral treatment for smoking cessation while enrolled in the study (with the exception of the SC Quitline).

Exclusion criteria

1. Participants who are dependent on substances other than nicotine. 2. Women who are pregnant during the clinical assessment session or either of the fMRI sessions. These participants must agree to notify the study staff if they become pregnant during the study.

Design outcomes

Primary

MeasureTime frameDescription
Mean Craving Questionnaire Score, Response to the Novel Cueup to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a Craving Questionnaire survey at multiple timepoints during each visit (baseline, and after each cue exposure). The craving questionnaire is the average of four statements about craving for cigarettes (e.g., I have an urge for a cigarette), and the participants rate how they agree with the statements at that moment on a scale of 1 to 5 (1 = strongly disagree and 5 = strongly agree). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.
Mean Cigarettes Smoked Per Dayup to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26Cigarettes Smoked per Day were recorded daily and summarized at follow-up visits

Secondary

MeasureTime frameDescription
Percentage of Smoking Daysup to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26Cigarettes Smoking days were recorded daily and summarized at follow-up visits. The percentage of days since last follow up visit where smoking is recorded is reported
Mean Mood-Craving Response to the Novel Cueup to 24 weeks, Baseline, 24 Hours, Weeks 2, 4, 6, 8, 12, and 24At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a mood craving during each visit. The mood craving form is a single item question ranging from 0 (no craving) to 100 (greatest craving possible). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Countries

United States

Participant flow

Participants by arm

ArmCount
R-E (Retrieval Extinction)
83 anticipated participants will undergo 3 sessions on consecutive days of the Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' smoking-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of smoking-related cues (e.g., pictures). Participants will also receive a lab-based smoking-related cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
81
NR-E (No R-E)
83 anticipated participants will undergo 3 sessions on consecutive days of the control Retrieval Extinction Training (RET) intervention consisting of a 5-minute 'retrieval' non-smoking or neutral-content video followed 10 minutes later by 1 hour of 'extinction' training consisting of four sequences of non-smoking or neutral cues (e.g., pictures). Participants will also receive a lab-based non-smoking or neutral cue-reactivity experience during the baseline assessment and 24-hour follow-up test.
82
Total163

Baseline characteristics

CharacteristicNR-E (No R-E)TotalR-E (Retrieval Extinction)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants6 Participants2 Participants
Age, Categorical
Between 18 and 65 years
78 Participants157 Participants79 Participants
Age, Continuous48.5 years
STANDARD_DEVIATION 11
48.2 years
STANDARD_DEVIATION 11.2
47.9 years
STANDARD_DEVIATION 11.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
14 Participants33 Participants19 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
67 Participants128 Participants61 Participants
Region of Enrollment
United States
82 participants163 participants81 participants
Sex: Female, Male
Female
41 Participants79 Participants38 Participants
Sex: Female, Male
Male
41 Participants84 Participants43 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 810 / 82
other
Total, other adverse events
0 / 810 / 82
serious
Total, serious adverse events
0 / 810 / 82

Outcome results

Primary

Mean Cigarettes Smoked Per Day

Cigarettes Smoked per Day were recorded daily and summarized at follow-up visits

Time frame: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26

Population: study population includes all participants that returned for a follow up visit at 2-weeks post intervention or later.

ArmMeasureGroupValue (MEAN)Dispersion
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day26 Weeks8.5 Average Cigarettes Smoked Per DayStandard Deviation 11.9
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per DayStudy Baseline9.4 Average Cigarettes Smoked Per DayStandard Deviation 7.7
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day2 weeks7.2 Average Cigarettes Smoked Per DayStandard Deviation 9
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day4 Weeks7.5 Average Cigarettes Smoked Per DayStandard Deviation 6.6
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day6 weeks8.1 Average Cigarettes Smoked Per DayStandard Deviation 8.4
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day8 weeks8.3 Average Cigarettes Smoked Per DayStandard Deviation 8.4
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day12 Weeks8.1 Average Cigarettes Smoked Per DayStandard Deviation 8.2
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day16 weeks8.5 Average Cigarettes Smoked Per DayStandard Deviation 10.8
R-E (Retrieval Extinction)Mean Cigarettes Smoked Per Day21 Weeks9 Average Cigarettes Smoked Per DayStandard Deviation 11.6
NR-E (No R-E)Mean Cigarettes Smoked Per Day16 weeks7.8 Average Cigarettes Smoked Per DayStandard Deviation 7
NR-E (No R-E)Mean Cigarettes Smoked Per Day8 weeks7.7 Average Cigarettes Smoked Per DayStandard Deviation 6.5
NR-E (No R-E)Mean Cigarettes Smoked Per DayStudy Baseline10.1 Average Cigarettes Smoked Per DayStandard Deviation 7.7
NR-E (No R-E)Mean Cigarettes Smoked Per Day26 Weeks7.1 Average Cigarettes Smoked Per DayStandard Deviation 6.5
NR-E (No R-E)Mean Cigarettes Smoked Per Day2 weeks6.7 Average Cigarettes Smoked Per DayStandard Deviation 6.7
NR-E (No R-E)Mean Cigarettes Smoked Per Day12 Weeks7.7 Average Cigarettes Smoked Per DayStandard Deviation 6.3
NR-E (No R-E)Mean Cigarettes Smoked Per Day4 Weeks8.2 Average Cigarettes Smoked Per DayStandard Deviation 8.5
NR-E (No R-E)Mean Cigarettes Smoked Per Day21 Weeks7.5 Average Cigarettes Smoked Per DayStandard Deviation 6.6
NR-E (No R-E)Mean Cigarettes Smoked Per Day6 weeks7.9 Average Cigarettes Smoked Per DayStandard Deviation 7.1
Primary

Mean Craving Questionnaire Score, Response to the Novel Cue

At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a Craving Questionnaire survey at multiple timepoints during each visit (baseline, and after each cue exposure). The craving questionnaire is the average of four statements about craving for cigarettes (e.g., I have an urge for a cigarette), and the participants rate how they agree with the statements at that moment on a scale of 1 to 5 (1 = strongly disagree and 5 = strongly agree). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Time frame: up to 24 weeks, Baseline, 24 hours, Weeks 2, 4, 6, 8, 12, and 24

Population: Participant included are those randomized to study treatment and return for at least 1 study visit. Mean response to the 4 CQ items and standard deviations to the novel cues are listed.

ArmMeasureGroupValue (MEAN)Dispersion
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel CueStudy Baseline3.43 score on a scale, average of 4 responsesStandard Deviation 0.99
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue24 Hours2.55 score on a scale, average of 4 responsesStandard Deviation 1.16
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue2 Weeks2.40 score on a scale, average of 4 responsesStandard Deviation 0.95
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue4 Weeks2.49 score on a scale, average of 4 responsesStandard Deviation 0.99
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue6 Weeks2.33 score on a scale, average of 4 responsesStandard Deviation 1.04
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue8 Weeks2.39 score on a scale, average of 4 responsesStandard Deviation 0.95
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue12 Weeks2.21 score on a scale, average of 4 responsesStandard Deviation 1.08
R-E (Retrieval Extinction)Mean Craving Questionnaire Score, Response to the Novel Cue24 Weeks1.96 score on a scale, average of 4 responsesStandard Deviation 1.03
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue24 Weeks1.97 score on a scale, average of 4 responsesStandard Deviation 0.99
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue24 Hours2.88 score on a scale, average of 4 responsesStandard Deviation 1.07
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel CueStudy Baseline3.73 score on a scale, average of 4 responsesStandard Deviation 0.96
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue6 Weeks2.42 score on a scale, average of 4 responsesStandard Deviation 1.05
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue12 Weeks2.31 score on a scale, average of 4 responsesStandard Deviation 1.12
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue2 Weeks2.59 score on a scale, average of 4 responsesStandard Deviation 1.14
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue8 Weeks2.25 score on a scale, average of 4 responsesStandard Deviation 1.06
NR-E (No R-E)Mean Craving Questionnaire Score, Response to the Novel Cue4 Weeks2.60 score on a scale, average of 4 responsesStandard Deviation 1.09
Secondary

Mean Mood-Craving Response to the Novel Cue

At each visit (baseline, intervention sessions, and follow-up test sessions), participants will complete a mood craving during each visit. The mood craving form is a single item question ranging from 0 (no craving) to 100 (greatest craving possible). This measure will examine the behavioral response to the novel cue over the course of the study, and differences in response between the R-E arms and NR-E arms.

Time frame: up to 24 weeks, Baseline, 24 Hours, Weeks 2, 4, 6, 8, 12, and 24

Population: Participant included are those randomized to study treatment and return for at least 1 study visit. Mean mood-Craving response and standard deviations to the novel cues are listed.

ArmMeasureGroupValue (MEAN)Dispersion
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue24 Weeks23.1 score on a scale, 0-100Standard Deviation 27.1
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel CueStudy Baseline62.1 score on a scale, 0-100Standard Deviation 29.2
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue24 Hours38.1 score on a scale, 0-100Standard Deviation 29.7
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue2 Weeks32.3 score on a scale, 0-100Standard Deviation 26.5
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue4 Weeks33.1 score on a scale, 0-100Standard Deviation 29.6
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue6 Weeks29.7 score on a scale, 0-100Standard Deviation 27.4
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue8 Weeks31.8 score on a scale, 0-100Standard Deviation 25.1
R-E (Retrieval Extinction)Mean Mood-Craving Response to the Novel Cue12 Weeks29.6 score on a scale, 0-100Standard Deviation 27.6
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue12 Weeks31.3 score on a scale, 0-100Standard Deviation 29.4
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue24 Weeks23.3 score on a scale, 0-100Standard Deviation 29.6
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue4 Weeks33.4 score on a scale, 0-100Standard Deviation 31.2
NR-E (No R-E)Mean Mood-Craving Response to the Novel CueStudy Baseline69.5 score on a scale, 0-100Standard Deviation 24.2
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue8 Weeks30.5 score on a scale, 0-100Standard Deviation 29.6
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue24 Hours46.5 score on a scale, 0-100Standard Deviation 29.1
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue6 Weeks31.1 score on a scale, 0-100Standard Deviation 29.3
NR-E (No R-E)Mean Mood-Craving Response to the Novel Cue2 Weeks33.5 score on a scale, 0-100Standard Deviation 31.6
Secondary

Percentage of Smoking Days

Cigarettes Smoking days were recorded daily and summarized at follow-up visits. The percentage of days since last follow up visit where smoking is recorded is reported

Time frame: up to 26 weeks, Baseline, Weeks 2, 4, 6, 8, 12, 16, 21 and 26

Population: study population includes all participants that returned for a follow up visit at 2-weeks post intervention or later.

ArmMeasureGroupValue (MEAN)Dispersion
R-E (Retrieval Extinction)Percentage of Smoking DaysStudy Baseline98.5 percentage of days reported smokingStandard Deviation 5.3
R-E (Retrieval Extinction)Percentage of Smoking Days12 Weeks73.2 percentage of days reported smokingStandard Deviation 41.7
R-E (Retrieval Extinction)Percentage of Smoking Days4 Weeks76.1 percentage of days reported smokingStandard Deviation 39.2
R-E (Retrieval Extinction)Percentage of Smoking Days16 weeks68.2 percentage of days reported smokingStandard Deviation 43.8
R-E (Retrieval Extinction)Percentage of Smoking Days6 weeks77.1 percentage of days reported smokingStandard Deviation 38.9
R-E (Retrieval Extinction)Percentage of Smoking Days21 Weeks64.8 percentage of days reported smokingStandard Deviation 46.4
R-E (Retrieval Extinction)Percentage of Smoking Days8 weeks77 percentage of days reported smokingStandard Deviation 37.5
R-E (Retrieval Extinction)Percentage of Smoking Days26 Weeks62.4 percentage of days reported smokingStandard Deviation 44.4
R-E (Retrieval Extinction)Percentage of Smoking Days2 weeks72.5 percentage of days reported smokingStandard Deviation 37.8
NR-E (No R-E)Percentage of Smoking Days26 Weeks66.2 percentage of days reported smokingStandard Deviation 42.7
NR-E (No R-E)Percentage of Smoking Days2 weeks70.2 percentage of days reported smokingStandard Deviation 40
NR-E (No R-E)Percentage of Smoking Days4 Weeks74.7 percentage of days reported smokingStandard Deviation 39.4
NR-E (No R-E)Percentage of Smoking DaysStudy Baseline98.1 percentage of days reported smokingStandard Deviation 10.5
NR-E (No R-E)Percentage of Smoking Days6 weeks73.8 percentage of days reported smokingStandard Deviation 40
NR-E (No R-E)Percentage of Smoking Days8 weeks75.1 percentage of days reported smokingStandard Deviation 39
NR-E (No R-E)Percentage of Smoking Days12 Weeks74 percentage of days reported smokingStandard Deviation 37.4
NR-E (No R-E)Percentage of Smoking Days16 weeks70.7 percentage of days reported smokingStandard Deviation 42.5
NR-E (No R-E)Percentage of Smoking Days21 Weeks67.9 percentage of days reported smokingStandard Deviation 41.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026